{
  "success": true,
  "sourceFile": "input/Alexion_NCT04573309_Wilsons_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33
  ],
  "modelUsed": "gemini-2.5-pro",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Screened Set",
        "populationType": "Disposition",
        "instanceType": "AnalysisPopulation",
        "label": "Screened Set",
        "description": "The Screened Set will include all participants who signed an informed consent form (ICF).",
        "criteria": "Signed an informed consent form"
      },
      {
        "id": "pop_2",
        "name": "Enrolled Set",
        "populationType": "Disposition",
        "instanceType": "AnalysisPopulation",
        "label": "Enrolled Set",
        "description": "The Enrolled Set will include all participants who signed an ICF and were enrolled in the study.",
        "criteria": "Signed an ICF and were enrolled in the study"
      },
      {
        "id": "pop_3",
        "name": "Full Analysis Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "FA Set",
        "description": "The Full Analysis (FA) Set will include all participants who were enrolled and received at least 1 dose of study drug. The FA Set will be the primary population for all efficacy analyses.",
        "criteria": "Enrolled and received at least 1 dose of study drug"
      },
      {
        "id": "pop_4",
        "name": "Per Protocol Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "PP Set",
        "description": "The Per Protocol (PP) Set will include all participants in the FA Set who have no major protocol deviations that would impact the primary efficacy endpoint. The PP Set will be used for sensitivity analyses of the primary efficacy endpoint.",
        "criteria": "In the FA Set with no major protocol deviations impacting the primary efficacy endpoint"
      },
      {
        "id": "pop_5",
        "name": "Safety Set",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "label": "Safety Set",
        "description": "The Safety Set will include all participants who received at least 1 dose of study drug. The Safety Set will be used for all safety analyses.",
        "criteria": "Received at least 1 dose of study drug"
      },
      {
        "id": "pop_6",
        "name": "Pharmacokinetic Analysis Set",
        "populationType": "Pharmacokinetic",
        "instanceType": "AnalysisPopulation",
        "label": "PK Analysis Set",
        "description": "The Pharmacokinetic (PK) Analysis Set will include all participants in the Safety Set who have sufficient plasma concentration data to allow for the derivation of at least 1 PK parameter. The PK Analysis Set will be used for all PK analyses.",
        "criteria": "In the Safety Set with sufficient plasma concentration data to derive at least 1 PK parameter"
      },
      {
        "id": "pop_7",
        "name": "Pharmacodynamic Analysis Set",
        "populationType": "Pharmacodynamic",
        "instanceType": "AnalysisPopulation",
        "label": "PD Analysis Set",
        "description": "The Pharmacodynamic (PD) Analysis Set will include all participants in the Safety Set who have sufficient PD data to allow for the derivation of at least 1 PD parameter. The PD Analysis Set will be used for all PD analyses.",
        "criteria": "In the Safety Set with sufficient PD data to derive at least 1 PD parameter"
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "Age",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Age calculated as the integer part of the number of years from the date of birth to the date of informed consent."
      },
      {
        "id": "char_2",
        "name": "Sex",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Sex of the participant."
      },
      {
        "id": "char_3",
        "name": "Race",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Race of the participant."
      },
      {
        "id": "char_4",
        "name": "Ethnicity",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Ethnicity of the participant."
      },
      {
        "id": "char_5",
        "name": "Weight",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Weight (kg) at baseline."
      },
      {
        "id": "char_6",
        "name": "Height",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Height (cm) at baseline."
      },
      {
        "id": "char_7",
        "name": "Body Mass Index (BMI)",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Body Mass Index (kg/m2) at baseline."
      },
      {
        "id": "char_8",
        "name": "Time since initial diagnosis of WD",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Time since initial diagnosis of Wilson Disease."
      },
      {
        "id": "char_9",
        "name": "Baseline WD therapy",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Wilson Disease therapy at baseline."
      },
      {
        "id": "char_10",
        "name": "Baseline clinical presentation",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Baseline clinical presentation (eg, hepatic, neurologic, psychiatric, or asymptomatic)."
      },
      {
        "id": "char_11",
        "name": "Medical/Surgical History",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Medical and surgical history coded using MedDRA."
      },
      {
        "id": "char_12",
        "name": "Wilson Disease history",
        "dataType": "Text",
        "instanceType": "Characteristic",
        "description": "History of Wilson Disease, summarized separately."
      },
      {
        "id": "char_13",
        "name": "Prior medications for WD",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Prior medications used to treat Wilson Disease, summarized separately."
      },
      {
        "id": "char_14",
        "name": "Baseline copper balance",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Pretreatment assessment of copper balance measured from Day -4 through Day -1."
      },
      {
        "id": "char_15",
        "name": "Baseline molybdenum balance",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Pretreatment assessment of molybdenum balance measured from Day -4 through Day -1."
      }
    ],
    "summary": {
      "populationCount": 7,
      "characteristicCount": 15
    }
  }
}